BRITTANY LAMB: Open Payments
NPI 1750003778 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 115 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $359 · 2025 $1,975
Food & beverage: $1,975
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $331 |
| PFIZER INC. | 37 | $329 |
| Aucta Pharmaceuticals, Inc. | 18 | $200 |
| Axsome Therapeutics, Inc. | 6 | $182 |
| Neurocrine BioSciences, Inc. | 3 | $180 |
| Lundbeck LLC | 4 | $91 |
| SK Life Science, Inc. | 3 | $76 |
| JAZZ PHARMACEUTICALS INC. | 2 | $67 |
| ACADIA Pharmaceuticals Inc | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 4 | $62 |
Products named: NURTEC ODT, Motpoly XR, Symbravo, INGREZZA, BOTOX, QULIPTA, REXULTI, VYEPTI.
Industry payments across UT — which companies pay providers there.
